Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of Capecitabine (Xeloda) in Participants With Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]
This Phase 2 trial of capecitabine (Xeloda) in locally advanced or metastatic pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer [Phase 4]
A Phase 4 clinical trial update assessing a COX-2 inhibitor for adjuvant anticancer effects in bile duct cancer and pancreatic cancer; curre…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: Comparing Covered Self-expandable Metallic Stent (SEMS) Above/Across the Sphincter of Oddi [Phase 4]
Phase 4 trial comparing covered self-expandable metallic stents (SEMS) above vs. across the Sphincter of Oddi in bile duct cancer and pancre…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Sirolimus in Treating Patients With Advanced Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating sirolimus for advanced pancreatic cancer has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy [NA]
A randomized trial comparing pancreaticojejunostomy versus pancreaticogastrostomy reconstruction after pancreaticoduodenectomy has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: Combining Erlotinib Plus Bevacizumab and Gemcitabine Plus Capecitabine to Treat Advanced Pancreatic Cancer [Phase 1, Phase 2]
A completed Phase 1/2 trial investigated a four-drug combination of erlotinib, bevacizumab, gemcitabine, and capecitabine for advanced pancr…
-
CLINICAL_TRIALS trial_result · 2016-10-14Clinical Trial Update: A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) [Phase 2]
Phase 2 PERU trial evaluating UFT/Leucovorin with radiotherapy with or without cetuximab after induction gemcitabine plus capecitabine in lo…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Safety Study of ²¹²Pb-TCMC-Trastuzumab Radio Immunotherapy [Phase 1]
Phase 1 safety study of 212Pb-TCMC-Trastuzumab radioimmunotherapy has completed, evaluating safety in multiple HER2-expressing cancers. The …
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]
Phase 1, single-dose pilot study evaluating radiolabeled amatuximab (MORAb-009) in mesothelin-overexpressing cancers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma [Phase 2]
This clinical trial update reports on a Phase 2 study evaluating the efficacy and safety of PBI-05204 in patients with stage IV metastatic p…
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: Endoscopic Drainage of Collections After Pancreatic Surgery
This clinical trial update describes endoscopic drainage of postoperative collections after pancreatic surgery in pancreatic cancer patients…
-
CLINICAL_TRIALS trial_result · 2016-09-19Clinical Trial Update: A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer [Phase 2]
Phase II study evaluating gemcitabine plus erlotinib as adjuvant therapy for resected pancreatic cancer was terminated; results have been po…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Use of PET Imaging to Distinguish Malignant From Benign IPMN [NA]
Terminated clinical trial evaluating whether PET imaging can distinguish malignant from benign intraductal papillary mucinous neoplasms of t…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Multicolour Versus Monocolour Specimens Inking After Pancreaticoduodenectomy for Periampullary Cancer [NA]
A completed clinical trial comparing multicolour versus monocolour inking after pancreaticoduodenectomy for periampullary cancer. Sponsor: I…
-
CLINICAL_TRIALS trial_result · 2016-09-09Clinical Trial Update: Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients [NA]
This clinical trial update reports the completion of a study evaluating secretin-stimulated MRCP imaging in pancreatic cancer patients and t…
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Effect of Oncothermia on Improvement of Quality of Life in Unresectable Pancreatic Cancer Patients [Phase 1]
Phase 1 trial assessing oncothermia for improving quality of life in patients with unresectable pancreatic cancer. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2016-09-01Clinical Trial Update: A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer [Phase 1]
A Phase 1 study of a recombinant hGM-CSF–expressing herpes simplex virus for cancer treatment has completed Phase 1, indicating initial safe…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma [Phase 1]
A Phase 1 dose-escalation study evaluating Zactima in combination with chemotherapy for metastatic pancreatic cancer has completed. The tria…
-
CLINICAL_TRIALS trial_result · 2016-08-29Clinical Trial Update: Study of Ruxolitinib in Pancreatic Cancer Patients [Phase 2]
Phase 2 trial update for ruxolitinib in pancreatic cancer has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer [Phase 2]
Phase 2 pilot trial evaluating regulatory T-cell suppression with Ontak in metastatic pancreatic cancer has completed and results have been …
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer [Phase 4]
A Phase 4 trial evaluating first-line erlotinib in combination with gemcitabine for locally advanced unresectable or metastatic pancreatic c…
-
CLINICAL_TRIALS trial_result · 2016-08-18Clinical Trial Update: Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating gemcitabine plus nab-paclitaxel versus the FOLFIRINOX regimen with molecular profiling in patients with advance…
-
CLINICAL_TRIALS trial_result · 2016-08-11Clinical Trial Update: Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection [Phase 3]
A Phase 3 trial comparing nab-paclitaxel plus gemcitabine versus oxaliplatin with folinic acid and fluorouracil as second-line adjuvant ther…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Study of D-Methadone in Patients With Chronic Pain [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating D-Methadone in patients with chronic pain and various cancers has completed enrollment with results po…
-
CLINICAL_TRIALS trial_result · 2016-08-09Clinical Trial Update: Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment Decision [Phase 2]
Phase 2 trial evaluating adjuvant gemcitabine/cisplatin after surgical resection for pancreatic cancer; the study explored ERCC1 as a biomar…